| Ledinek A, Jazbec S, Drinovec I, et al. Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report. [JOURNAL ARTICLE] Mult Scler 2009 May 22. Abstract | Full Citation | Find Related Articles |
| Carroll W Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit. [JOURNAL ARTICLE] Mult Scler 2009 May 22. Abstract | Full Citation | Find Related Articles |
| Nielsen JM, Pohl C, Polman CH, et al. Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis. [JOURNAL ARTICLE] BMC Neurol 2009 May 20; 9(1):19. Abstract | Full Citation |
| Castelli-Haley J, Oleen-Burkey MA, Lage MJ, et al. Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis. [JOURNAL ARTICLE] Adv Ther 2009 May 14. Abstract | Full Citation |
| Lopategui Cabezas I, Cervantes Llano M, Pentón Rol G [Optic neuromyelitis: Main differences with multiple sclerosis.] [English Abstract, Journal Article] An Med Interna 2008 Jun; 25(6):294-6. Abstract | Full Citation | Find Related Articles |
| Cadavid D, Wolansky LJ, Skurnick J, et al. Efficacy of treatment of MS with IFN{beta}-1b or glatiramer acetate by monthly brain MRI in the BECOME study. [JOURNAL ARTICLE] Neurology 2009 Mar 11. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Durelli L, Barbero P, Cucci A, et al. Neutralizing antibodies in multiple sclerosis patients treated with 375 mug interferon-beta-1b. [JOURNAL ARTICLE] Expert Opin Biol Ther 2009 Mar 11. Abstract | Full Citation | Find Related Articles |
| Achiron A, Fredrikson S Lessons from randomised direct comparative trials. [EDITORIAL] J Neurol Sci 2009 Feb 1.:S19-S24. Abstract | Full Citation |
| Eckermann S, Coory M, Willan AR Indirect comparison: relative risk fallacies and odds solution. [JOURNAL ARTICLE] J Clin Epidemiol 2009 Jan 27. Abstract | Full Citation | Find Related Articles |
| Lazzaro C, Bianchi C, Peracino L, et al. Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon beta-1b. [Journal Article, Research Support, Non-U.S. Gov't] Neurol Sci 2009 Feb; 30(1):21-31. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
 |